Heron Therapeutics Inc (NASDAQ:HRTX) shares, rose in value, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.84.
Actively observing the price movement in the last trading, the stock closed the session at $1.84, falling within a range of $1.7909 and $1.86. The value of beta (5-year monthly) was 1.397. Referring to stock’s 52-week performance, its high was $3.93, and the low was $1.04. On the whole, HRTX has fluctuated by -24.90% over the past month.
With the market capitalization of Heron Therapeutics Inc currently standing at about $280.29 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 157.27M, with a low estimate of 35.25M and a high estimate of 38.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 37.42M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HRTX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of HRTX currently trading nearly -11.69% and -11.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.27, while the 7-day volatility ratio is showing 4.56% which for the 30-day chart, stands at 6.39%. Furthermore, Heron Therapeutics Inc (HRTX)’s beta value is 1.39, and its average true range (ATR) is 0.15.
A comparison of Heron Therapeutics Inc (HRTX) with its peers suggests the former has fared considerably weaker in the market. HRTX showed an intraday change of 0.00% in last session, and over the past year, it shrunk by -37.20%%.
Data on historical trading for Heron Therapeutics Inc (NASDAQ:HRTX) indicates that the trading volumes over the past 10 days have averaged 1.29 and over the past 3 months, they’ve averaged 1.71 million. According to company’s latest data on outstanding shares, there are 152.13 million shares outstanding.
Nearly 0.91% of Heron Therapeutics Inc’s shares belong to company insiders and institutional investors own 75.69% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 32.52 million shares as on 2025-03-31, resulting in a short ratio of 16.42. According to the data, the short interest in Heron Therapeutics Inc (HRTX) stood at 2757.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 31.33 million. The stock has risen by 20.26% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HRTX stock heading into the next quarter.
